We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
-7.04%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.97B
AUM Growth
-$164M
Cap. Flow
+$28.5M
Cap. Flow %
1.45%
Top 10 Hldgs %
74.92%
Holding
37
New
6
Increased
2
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
ARDX icon
Ardelyx
ARDX
+$95.7M
2
HIVE
Aerohive Networks
HIVE
+$40M
3
ROKA
Sorrento Tech, Inc. Common Stock
ROKA
+$35M
4
CRCM
CARE.COM, INC.
CRCM
+$31.1M
5
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
+$20.3M

Top Sells

Rank Stock Value
1
FIO
FUSION-IO INC COM
FIO
+$79.5M
2
ITMN
INTERMUNE INC
ITMN
+$59.2M
3
EPZM
Epizyme, Inc
EPZM
+$40.3M
4
CVT
CVENT, INC.
CVT
+$26.4M
5
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
+$6.74M

Sector Composition

Rank Sector Weight
1 Healthcare 48.22%
2 Communication Services 19.23%
3 Technology 18.17%
4 Consumer Discretionary 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRPN icon
1
Groupon
GRPN
$1.07B
$363M 18.45%
2,717,579
– –
TSRO
2
DELISTED
TESARO, Inc.
TSRO
$265M 13.48%
9,854,255
– –
OPWR
3
DELISTED
OPOWER INC COM STK (DE)
OPWR
$170M 8.62%
8,997,290
– –
EPZM
4
DELISTED
Epizyme, Inc
EPZM
$140M 7.1%
5,149,740
-1,296,349
-20% -$40.3M
CVT
5
DELISTED
CVENT, INC.
CVT
$127M 6.44%
4,994,106
-1,002,106
-17% -$26.4M
CLVS
6
DELISTED
Clovis Oncology, Inc.
CLVS
$103M 5.26%
2,279,781
– –
ARDX icon
7
Ardelyx
ARDX
$1.25B
$94.1M 4.78%
+6,621,199
New +$95.7M
SUPN icon
8
Supernus Pharmaceuticals
SUPN
$2.71B
$92.5M 4.7%
10,650,000
– –
HPTX
9
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$60.1M 3.06%
2,384,221
– –
CBIO
10
Crescent Biopharma
CBIO
$568M
$59.5M 3.02%
85,751
– –
TRIV
11
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$57.1M 2.9%
3,945,191
– –
RNA
12
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$54.6M 2.78%
6,480,171
– –
HIVE
13
DELISTED
Aerohive Networks
HIVE
$39M 1.98%
+4,861,455
New +$40M
FOLD
14
DELISTED
Amicus Therapeutics
FOLD
$33.6M 1.71%
5,653,029
– –
VIRX
15
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$33.3M 1.69%
22,187
-4,654
-17% -$6.74M
ROKA
16
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$32.4M 1.65%
+322,043
New +$35M
WIFI
17
DELISTED
Boingo Wireless, Inc.
WIFI
$31.9M 1.62%
4,467,960
– –
CRCM
18
DELISTED
CARE.COM, INC.
CRCM
$26.6M 1.35%
+3,260,989
New +$31.1M
TRVN
19
DELISTED
Trevena, Inc.
TRVN
$24.5M 1.24%
6,099
– –
NKTR icon
20
Nektar Therapeutics
NKTR
$2.31B
$22M 1.12%
121,707
– –
VTAE
21
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$19.9M 1.01%
+2,613,199
New +$20.3M
LXRX icon
22
Lexicon Pharmaceuticals
LXRX
$1.03B
$16.5M 0.84%
1,668,000
– –
OREX
23
DELISTED
Orexigen Therapeutics, Inc.
OREX
$15.8M 0.8%
370,900
+177,370
+92% +$9.52M
MM
24
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
$15.3M 0.78%
8,224,752
– –
DZSI
25
DELISTED
DZS Inc. Common Stock
DZSI
$12.9M 0.66%
956,258
– –
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.76B AUM 13.06% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return

NEA Management Company's Q3 2014 Portfolio in Review

As of Q3 2014, NEA Management Company held 37 positions worth $1.97B, down 7.7% from $2.13B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

NEA Management Company's Q3 2014 filing shows 6 new, 2 increased, 3 reduced and 2 closed positions. Its largest new stake was Ardelyx: 6,621,199 shares worth $94.1M. The largest sale was FUSION-IO INC COM, an estimated $79.5M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 46% a quarter earlier, followed by Communication Services and Technology.

  • NEA Management Company's largest Q3 2014 buy was Ardelyx: 6,621,199 shares worth $94.1M.
  • NEA Management Company added most to Orexigen Therapeutics, Inc. in Q3 2014, an estimated $9.52M increase.
  • NEA Management Company's biggest Q3 2014 reduction was Epizyme, Inc, cutting an estimated $40.3M.
  • NEA Management Company fully exited FUSION-IO INC COM in Q3 2014, selling an estimated $79.5M.
  • NEA Management Company's ten largest holdings make up 75% of its $1.97B portfolio in Q3 2014.
  • NEA Management Company opened 6 new positions and closed 2 in Q3 2014.
  • NEA Management Company's portfolio value fell 7.7% quarter-over-quarter to $1.97B.

Based on NEA Management Company's 13F filing for Q3 2014, filed 24 Oct 2014.